Antitumor Agents. 282. 2′-(R)-O-Acetylglaucarubinone, a Quassinoid fromOdyendyea gabonensisAs a Potential Anti-Breast and Anti-Ovarian Cancer Agent
Authors:
- Yoshihide UsamiYUYoshihide Usami
- Kyoko Nakagawa-GotoKNKyoko Nakagawa-Goto
- Jing-Yu LangJLJing-Yu Lang
- Yoon KimYKYoon Kim
- Chin-Yu LaiCLChin-Yu Lai
- Masuo GotoMGMasuo Goto
- Nobuko SakuraiNSNobuko Sakurai
- Masahiko TaniguchiMTMasahiko Taniguchi
- Toshiyuki AkiyamaTAToshiyuki Akiyama
- Susan L. Morris-NatschkeSMSusan L. Morris-Natschke
- Kenneth F. BastowKBKenneth F. Bastow
- Gordon CraggGCGordon Cragg
- 25 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 73 (9) , 1553-1558
Abstract
A new quassinoid, designated 2′-(R)-O-acetylglaucarubinone (1), and seven known quassinoids (2−8) were isolated, using bioactivity-guided separation, from the bark of Odyendyea gabonensis (Pierre) Engler [syn. Quassia gabonensis Pierre]. The structure of 1 was determined by spectroscopic analysis and by semisynthesis from glaucarubolone. Complete 1H and 13C NMR assignments of compounds 1−8 were also established from detailed analysis of two-dimensional NMR spectra, and the reported configurations in odyendene (7) and odyendane (8) were corrected. Compound 1 showed potent cytotoxicity against multiple cancer cell lines. Further investigation using various types of breast and ovarian cancer cell lines suggested that 1 does not target the estrogen receptor or progesterone receptor. When tested against mammary epithelial proliferation in vivo using a Brca1/p53-deficient mice model, 1 also caused significant reduction in mammary duct branching.Keywords
This publication has 24 references indexed in Scilit:
- Antitumor Agents. 272. Structure−Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone AnaloguesJournal of Medicinal Chemistry, 2010
- Altered Proliferation and Differentiation Properties of Primary Mammary Epithelial Cells from BRCA1 Mutation CarriersCancer Research, 2009
- Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53–Mediated Mouse Mammary TumorsCancer Research, 2008
- Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone AntagonistScience, 2006
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Multiple Myeloma Regression Mediated by BruceantinClinical Cancer Research, 2004
- Mode of action of the anticancer quassinoids — Inhibition of the plasma membrane NADH oxidaseLife Sciences, 1998
- Antitumor Agents LIX: Effects of Quassinoids on Protein Synthesis of a Number of Murine Tumors and Normal CellsJournal of Pharmaceutical Sciences, 1983
- Antitumor Agents XLVI: In Vitro Effects of Esters of Brusatol, Bisbrusatol, and Related Compounds on Nucleic Acid and Protein Synthesis of P-388 Lymphocytic Leukemia CellsJournal of Pharmaceutical Sciences, 1982
- Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoidsJournal of Medicinal Chemistry, 1976